Scancell Holdings plc (LSE:SCLP), the Oxford-based clinical-stage immunotherapy developer, will hold its General Meeting at 11.00 a.m. (London time) on 20 October 2026 at the offices of Cooley (UK) LLP, 22 Bishopsgate, London EC2N 4BQ. Shareholders will vote on the debt facility from funds …
At the 14 October 2026 close, 1,050p, up 0.10%. A one-session change is best read alongside recent trading ranges, turnover, sector performance and any company-specific announcement. A positive move does not necessarily signal a change in long-term fundamentals, and a decline does not automatically …
ConvaTec Group plc (LSE:CTEC) was in focus around the 14 October 2026 session, when advanced about 1.7% on 14 October. The stock sits within the FTSE 100 Index and should be assessed against both company-specific developments and wider market conditions.
GSK plc (LSE:GSK) was in focus around the 14 October 2026 session, when rose around 3.6% on 14 October. The stock sits within the FTSE 100 Index and should be assessed against both company-specific developments and wider market conditions.
For 14 October 2026, a verified closing move is not included here; investors should check the official closing record before relying on a precise daily percentage. A one-session change is best read alongside recent trading ranges, turnover, sector performance and any company-specific announcement. A …
Haleon PLC (LSE:HLN) was on investor watchlists on 14 October 2026 as the FTSE 100 rose and sector rotation influenced UK equities. The available closing data for this stock: +1.97% to 362.1p.
Why is the company in focus?GSK (LSE:GSK) is in focus following the latest disclosed development: director/pdmr shareholding. The headline gives investors a reason to revisit the company's near-term priorities, but the significance depends on whether it changes earnings expectations, cash generation, balance-sheet risk, strategy …
Arecor Therapeutics Plc (LSE:AREC) is drawing investor attention through pharmaceutical formulation partnerships. The most important analytical question is how recent developments could affect the underlying investment case. Investors are monitoring partner milestones, clinical progress and funding. The stock trades in London; investors should verify …
Eden Research plc (LSE:EDEN) is drawing investor attention through biopesticide commercialisation and regulatory approvals. The most important analytical question is how recent developments could affect the underlying investment case. Investors are monitoring distribution reach, product registrations and profitability. The stock trades in London; investors …
ImmuPharma plc (LSE:IMM) is drawing investor attention through clinical development and funding sensitivity. The most important analytical question is how recent developments could affect the underlying investment case. Investors are monitoring clinical updates, regulatory interactions and cash requirements. The stock trades in London; investors …